Stock Symbol:

BCRX

Company Name:

BioCryst Pharmaceuticals, Inc.

Company Description:

Designs and develops novel, small-molecule pharmaceutical products for treatment of immunological, viral, and cardiovascular diseases and disorders using structure-based drug design.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

M-J-S-D

Stock Exchange:

NASDAQ

Predicted Split Price:

$31.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

2.2%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.